WallStSmart
PCVX

Vaxcyte Inc

NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY

$53.99
-2.87% today

Updated 2026-06-05

Market cap
$6.85B
P/E ratio
P/S ratio
EPS (TTM)
$-6.89
Dividend yield
52W range
$29 – $65
Volume
1.4M

Vaxcyte Inc (PCVX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$39.63M$70.80M$65.70M$392.83M$324.34M$1.01B$1.41B$3.51B$3.05B
Cash & equivalents$36.14M$66.09M$58.98M$386.20M$68.98M$834.66M$397.45M$387.88M$173.96M
Current assets$36.35M$66.67M$61.72M$389.00M$256.35M$942.55M$1.10B$1.79B$1.63B
Total liabilities$8.69M$128.53M$172.07M$46.98M$40.32M$52.56M$167.45M$205.50M$360.45M
Current liabilities$4.26M$6.71M$11.05M$46.86M$28.72M$40.52M$145.34M$140.18M$205.75M
Long-term debt$3.76M$3.65M$450000.00
Shareholder equity$30.94M$-57.73M$-106.37M$345.84M$284.02M$953.61M$1.24B$3.31B$2.69B
Retained earnings$-29.59M$-59.07M$-109.35M$-198.56M$-298.64M$-522.13M$-924.39M$-1.39B$-2.15B
Accounts receivable$200000.00$300000.00$1.20M$1.00M$3.61M$20.66M$46.56M
Inventory$-200000.00$-300000.00$-1.20M$-1.00M$-6.16M
Goodwill

Frequently asked questions

How much free cash flow does PCVX generate?

PCVX produced $-669.29M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PCVX's balance sheet healthy?

PCVX holds $173.96M in cash and equivalents against — in long-term debt, on $2.69B of shareholder equity. That debt is best read against the cash flow the business throws off each year.